Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3435 of 6351
-
Can an antibiotic save your sight? new study tests minocycline for macular degeneration
Disease control CompletedBackground: Age-related macular degeneration (AMD) is the main reason older people lose their vision. It affects the macula, the center of the retina needed for sharp, clear vision. Researchers want to see if an antibiotic can help people with an advanced form of AMD, Geographic…
Phase 2 • Sponsor: National Eye Institute (NEI) • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Experimental brain tumor combo shows promise but trial halted early
Disease control Stopped earlyBackground: Zotiraciclib (TG02) is an investigational drug that penetrates the blood-brain barrier and might treat brain tumors. Temozolomide (TMZ) is a drug used to treat brain tumors. Objective: To find out if Zotiraciclib (TG02) is safe, and to find out if it in combination…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New hope for ostomy patients: drug cuts dangerous fluid loss
Symptom relief CompletedDuring rectal or complex digestive surgery with multiple digestive resections and anastomosis, the creation of enterostomy is a common procedure. In France, it is estimated that 20000 patients have an ileostomy and 16000 new digestive stomas are formed each year with approximatel…
Phase 2 • Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Massive Alzheimer's study aims to sharpen diagnosis and trial design
Knowledge-focused CompletedSince its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) has been realized in informing the design of therapeutic trials in AD. ADNI3 continues the previously funded ADNI-1, ADNI-GO, and ADNI-2 studies that have been combined public/…
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Could bright light fix Parkinson's sleep troubles?
Symptom relief OngoingDisruption of sleep and alertness is one of the most disabling non-motor symptoms of Parkinson's disease (PD). Mechanisms leading to impaired sleep and alertness in PD are not well understood, and treatment options remain limited. The proposed research will examine markers of the…
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Experimental cancer drug NEV801 enters first human tests
Disease control CompletedThis study is a first-in-human, multicenter, open-label, nonrandomized, dose-escalation trial to be conducted in 2 sequential parts: * Part A (Dose Escalation) in subjects with advanced malignancies * Part B (Dose Confirmation) in subjects with tumor type(s) to be determined by …
Phase 1 • Sponsor: Neovia Oncology Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Fertility hope: egg freezing before breast cancer chemo tested in new study
Disease control OngoingThe aim of the study is to perform a French multicenter prospective interventional study in order to assess the feasibility and safety of ovarian hyperstimulation for oocyte / embryo cryopreservation in young women with breast cancer. The oncologic and reproductive benefit / risk…
Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Texting Moms-to-Be: a simple way to tame diabetes in pregnancy?
Disease control OngoingDiabetes is a common complication of pregnancy that increases risks for both the mother and baby. Poorly controlled diabetes has been associated with very large babies, congenital heart defects, stillbirth, birth trauma, and maternal infections among other complications. Patients…
Sponsor: St. Louis University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New toolkit and training aim to ease tooth brushing struggles for kids with autism
Symptom relief CompletedA randomized controlled trial (at sites) comparing the efficacy of the established AIR-P Dental Toolkit (control condition) to a combined regimen involving the Dental Toolkit and parent-mediated behavioral intervention (intervention condition) to improve home dental care, oral he…
Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New cancer drug shows promise in early trial
Disease control CompletedThe main objective of the dose-escalation part of the trial is to determine the safety and tolerability, and to determine the Maximum Tolerated Dose and/or the Recommended Phase 2 Dose (RP2D) of BI 754091 on the basis of patients with dose-limiting toxicities (DLTs) in patients w…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Dietary oil shows promise for rare muscle disorder
Symptom relief CompletedBackground: Patients with the sugar metabolism disorder, Glycogen Storage Disease Type V, have insufficient breakdown of sugar stored as, glycogen, within the cells. The investigators know from previous studies with McArdle patients, that they not only have a reduced sugar metabo…
Phase 2 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Symptom relief
Last updated Jun 26, 2026 13:57 UTC
-
New implant aims to stop Post-Prostate surgery leaks
Disease control OngoingWe wish to set up a multicentric prospective observational study across France to collate data on the efficacy and tolerance of the Male REMEEX® device in patients with moderate stress urinary incontinence following radical prostatectomy. Patient satisfaction, improvement in qual…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Heart MRI breakthrough could spot hidden risks in thousands
Knowledge-focused Recruiting nowMagnetic properties of myocardial tissue change in the presence of disease. This is detectable in the change of rate of magnetic relaxation, and measurable by T1 and T2 mapping using cardiovascular magnetic resonance (CMR). These markers provide novel quantifiable imaging measure…
Sponsor: Johann Wolfgang Goethe University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
New cancer drug CFI-402257 enters first human trial
Disease control CompletedThis is a phase 1 study of investigational agent CFI-402257 in patients with advanced cancer. The purpose of this study is to see how safe and tolerable CFI-402257 is in cancer patients as well as the pharmacokinetics (PK). This study is the first time that CFI-402257 is given to…
Phase 1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
HIV drug extension study halted early: what happened?
Disease control Stopped earlyPRO 140\_CD02 Extension study seeks to evaluate the long-term efficacy, safety and tolerability of PRO 140 weekly injection in combination with Optimized Background Therapy (OBT) in patients infected with Human Immunodeficiency virus (HIV-1).
Phase 2/3 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Electric brain zaps tested for chronic pain relief
Symptom relief CompletedThe aim of this study is to evaluate, versus placebo, the analgesic efficacy of the opercular-insular cortex stimulation with Transcranial Direct Current Stimulation (tDCS), in both healthy subjects and chronic neuropathic pain patients. In healthy subjects analgesia by tDCS will…
Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Chewing your way to a healthier brain?
Disease control CompletedOral health is a critical factor of systemic health, although usually forgotten. A potential relation between cognitive deficits and oral diseases has been suggested. Adult cognitive dysfunctions have a high impact, not only economic, but social and in the family environment. Bas…
Sponsor: Universidad de Granada • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Heart-Smart chemo: new infusion method aims to protect AML patients
Symptom relief CompletedThis pilot clinical trial studies the side effects of cytarabine and daunorubicin hydrochloride and to see how well they work in treating patients with newly diagnosed acute myeloid leukemia. Drugs used in chemotherapy, such as cytarabine and daunorubicin hydrochloride, work in d…
Phase 1 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Smartphone app could help RA patients stay ahead of flares
Disease control CompletedThe overall objective of this proposal is to implement a smart phone application (app) + population management system to monitor rheumatoid arthritis (RA) disease activity between scheduled physician office visits. The population management system includes: 1) a web-based dashboa…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:17 UTC
-
Could a tiny dose of IL-2 help liver transplant patients ditch heavy drugs?
Disease control CompletedThe purpose of this investigation is to study if very low dose IL-2, given to liver transplant patients by subcutaneous (under the skin) injections, over a 4 week period of time, will cause an increase in the number of Treg cells in the blood.
Phase 2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC